Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Expression of CD20 in B Cell Precursor Acute Lymphoblastic Leukemia.

Kumar J, Khan AA, Saraf A, Bhargava M.

Indian J Hematol Blood Transfus. 2014 Mar;30(1):16-8. doi: 10.1007/s12288-012-0216-1. Epub 2012 Dec 6.

2.

[Expression of CD20 in B-cell precursor acute lymphoblastic leukemia and its correlation with clinical outcomes].

Chen XX, Yuan LX, Zhang G, Wan CM, Huo WY, Tang X, Ai Y, Wan Z, Zhu YP, Gao J.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2014 Jul;45(4):658-63. Chinese.

PMID:
25286695
3.

CD20 and Outcome of Childhood Precursor B-cell Acute Lymphoblastic Leukemia: A Meta-analysis.

Ou DY, Luo JM, Ou DL.

J Pediatr Hematol Oncol. 2015 Apr;37(3):e138-42. doi: 10.1097/MPH.0000000000000256.

PMID:
25222059
4.

Adverse prognostic significance of CD20 expression in adults with Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia.

Maury S, Huguet F, Leguay T, Lacombe F, Maynadié M, Girard S, de Labarthe A, Kuhlein E, Raffoux E, Thomas X, Chevallier P, Buzyn A, Delannoy A, Chalandon Y, Vernant JP, Rousselot P, Macintyre E, Ifrah N, Dombret H, Béné MC; Group for Research on Adult Acute Lymphoblastic Leukemia.

Haematologica. 2010 Feb;95(2):324-8. doi: 10.3324/haematol.2009.010306. Epub 2009 Sep 22.

5.

CD20 up-regulation in pediatric B-cell precursor acute lymphoblastic leukemia during induction treatment: setting the stage for anti-CD20 directed immunotherapy.

Dworzak MN, Schumich A, Printz D, Pötschger U, Husak Z, Attarbaschi A, Basso G, Gaipa G, Ratei R, Mann G, Gadner H.

Blood. 2008 Nov 15;112(10):3982-8. doi: 10.1182/blood-2008-06-164129. Epub 2008 Sep 9.

6.

Prognostic significance of CD20 expression in adults with de novo precursor B-lineage acute lymphoblastic leukemia.

Thomas DA, O'Brien S, Jorgensen JL, Cortes J, Faderl S, Garcia-Manero G, Verstovsek S, Koller C, Pierce S, Huh Y, Wierda W, Keating MJ, Kantarjian HM.

Blood. 2009 Jun 18;113(25):6330-7. doi: 10.1182/blood-2008-04-151860. Epub 2008 Aug 14.

7.

The immunophenotypes of blast cells in B-cell precursor acute lymphoblastic leukemia: how different are they from their normal counterparts?

Sędek Ł, Bulsa J, Sonsala A, Twardoch M, Wieczorek M, Malinowska I, Derwich K, Niedźwiecki M, Sobol-Milejska G, Kowalczyk JR, Mazur B, Szczepański T.

Cytometry B Clin Cytom. 2014 Sep;86(5):329-39. doi: 10.1002/cyto.b.21176. Epub 2014 May 21.

9.

Chemoimmunotherapy with a modified hyper-CVAD and rituximab regimen improves outcome in de novo Philadelphia chromosome-negative precursor B-lineage acute lymphoblastic leukemia.

Thomas DA, O'Brien S, Faderl S, Garcia-Manero G, Ferrajoli A, Wierda W, Ravandi F, Verstovsek S, Jorgensen JL, Bueso-Ramos C, Andreeff M, Pierce S, Garris R, Keating MJ, Cortes J, Kantarjian HM.

J Clin Oncol. 2010 Aug 20;28(24):3880-9. doi: 10.1200/JCO.2009.26.9456. Epub 2010 Jul 26.

10.

[CD20 Expression in Adult Patients with B-lineage Acute Lymphoblastic Leukemia and Its Prognostic Significance].

Zhou J, Wang J, Liu H, Zheng HF, Ma L, Wang PF, Yan S, Fu CC.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2015 Jun;23(3):619-22. doi: 10.7534/j.issn.1009-2137.2015.03.003. Chinese.

PMID:
26117004
11.

Modulation of CD44 in acute lymphoblastic leukemia identifies functional and phenotypic differences of human B cell precursors.

Zittermann SI, Achino BI, Agriello EE, Halperín N, Ramhorst RE, Fainboim L.

Eur J Haematol. 2001 Jun;66(6):377-82.

PMID:
11488936
12.

[Clinical features and survival analysis of patients with CD20 positive adult B-lineage acute lymphoblastic leukemia].

Xu H, Wei X, Yin Q, Wang P, Mi R, Ai H, Wang X, Li Y, Zhu X, Zhang Y, Song Y.

Zhonghua Xue Ye Xue Za Zhi. 2015 Jan;36(1):4-9. doi: 10.3760/cma.j.issn.0253-2727.2015.01.002. Chinese.

PMID:
25641137
13.

CD20 expression has no prognostic role in Philadelphia-negative B-precursor acute lymphoblastic leukemia: new insights from the molecular study of minimal residual disease.

Mannelli F, Gianfaldoni G, Intermesoli T, Cattaneo C, Borlenghi E, Cortelazzo S, Cavattoni I, Pogliani EM, Fumagalli M, Angelucci E, Romani C, Ciceri F, Corti C, Scattolin A, Cortelezzi A, Mattei D, Audisio E, Spinelli O, Oldani E, Bosi A, Rambaldi A, Bassan R.

Haematologica. 2012 Apr;97(4):568-71. doi: 10.3324/haematol.2011.054064. Epub 2011 Nov 4.

14.

Expression of CD20 on acute lymphoblastic leukemia cells in children.

Pituch-Noworolska A, Hajto B, Mazur B, Sońta-Jakimczyk D, Balwierz W, Janota-Krawczyk E, Kowalska H, Malinowska I, Modzelewska M, Wasik M.

Neoplasma. 2001;48(3):182-7.

PMID:
11583286
15.

Prognostic significance of CD20 expression in childhood B-cell precursor acute lymphoblastic leukemia.

Jeha S, Behm F, Pei D, Sandlund JT, Ribeiro RC, Razzouk BI, Rubnitz JE, Hijiya N, Howard SC, Cheng C, Pui CH.

Blood. 2006 Nov 15;108(10):3302-4. Epub 2006 Aug 8.

16.

[Comparative analysis of blast immunophenotype between the diagnosis and relapse of childhood acute lymphoblastic leukaemia - implications for monitoring of minimal residual disease].

Bulsa J, Sedek Ł, Sońta-Jakimczyk D, Mazur B, Sobol G, Szczepański T.

Med Wieku Rozwoj. 2008 Oct-Dec;12(4 Pt 2):1045-50. Polish.

PMID:
19531824
17.

Establishment and characterization of human B cell precursor-leukemia cell lines.

Matsuo Y, Drexler HG.

Leuk Res. 1998 Jul;22(7):567-79. Review.

PMID:
9680106
18.

Interleukin 4 inhibits in vitro proliferation of leukemic and normal human B cell precursors.

Pandrau D, Saeland S, Duvert V, Durand I, Manel AM, Zabot MT, Philippe N, Banchereau J.

J Clin Invest. 1992 Nov;90(5):1697-706.

20.

CD20 expression in B-cell precursor acute lymphoblastic leukemia is common in Mexican patients and lacks a prognostic value.

Solano-Genesta M, Tarín-Arzaga L, Velasco-Ruiz I, Lutz-Presno JA, González-Llano O, Mancías-Guerra C, Rodríguez-Romo L, Ruiz-Delgado GJ, Ruiz-Argüelles GJ, Jaime-Pérez JC, Gómez-Almaguer D.

Hematology. 2012 Mar;17(2):66-70. doi: 10.1179/102453312X13221316477741.

PMID:
22664043

Supplemental Content

Support Center